移动健康应用程序用于心肌梗塞或PCI后的二次预防:随机对照试验的系统审查和元分析
Ioannis Skalidis1,2, Henri Lu3, Niccolo Maurizi3
1Institut Cardiovasculaire Paris-Sud, Hôpital Jacques Cartier, Ramsay-Santé, 91300 Massy, France.
Healthcare (Basel, Switzerland)
|August 14, 2025
概括
智能手机应用程序显著减少了心脏病发作或支架后患者的再入院. 这些移动健康工具改善了患者的结果和生活质量,支持心血管二次预防.
科学领域:
- 心脏病学 心脏病学
- 数字健康数字健康
- 医疗保健服务研究 医疗服务研究
背景情况:
- 移动健康 (mHealth) 应用程序为心肌梗塞 (MI) 或皮肤冠状动脉干预 (PCI) 后的二次预防提供了潜力.
- 基于应用程序的干预措施在减少医院再入院等关键结果的有效性需要系统评估.
研究的目的:
- 系统地评估基于智能手机应用程序的干预措施在减少心脏病发作或PCI康复的患者中计划外再入院的有效性.
主要方法:
- 在PubMed上对2020年1月至2025年4月期间发表的随机对照试验 (RCT) 进行了系统的文献搜索.
- 包括专注于用于心血管二次预防的智能手机应用程序和报告未计划住院再接收的研究.
- 使用随机效应模型进行聚合分析,确定了风险比率 (RR) 和95%置信区间 (CI);小组分析检查了随访持续时间和遵守情况.
主要成果:
- 四项涉及827名患者的RCT表明,与标准护理相比,基于应用程序的干预措施显著减少了未计划的重诊 (RR 0.45;95% CI:0.23-0.89).
- 随着更长的随访期和更高的患者坚持率,人们注意到了更大的益处.
- 患者报告结果的改善,包括与健康有关的生活质量,也被观察到,具有适度的异质性.
结论:
- 智能手机应用程序有望减少MI / PCI后患者的计划外住院再诊.
- 这些数字健康工具可以改善患者报告的结果,并可能是未来心血管保健模型的组成部分.
- 在应用程序设计中优先考虑持续的参与和个性化的功能对于最大化收益至关重要.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.6K
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
7.7K
相关概念视频
01:26Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
01:27Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:28Acute Coronary Syndrome IV: Interprofessional Care
27
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
27
01:29Cardiomyopathy V: Interprofessional Care
33
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
01:26Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35